Background And Objective: To assess the functional state of nigro-striatal pathway using FP-CIT-I-123 in patients with clinical diagnosis of Multiple System Atrophy (MSA) subtype C.
Patients And Methods: We included 10 patients with a clinical diagnosis of MSA-C and compared them with 10 patients diagnosed with essential tremor (controls) and 10 with Parkinson Disease (PD). The studies are evaluated by the striatum/occipital index (S/O). We calculated the diagnostic validity of the procedure by ROC curve analysis.
Results: The average value of the S/O index showed a mean of 1.48 (0.23), 1.59 (0.17) and 1.22 (0.16) respectively for MSA-C, control group (p=0.25) and PD (p=0.00). ROC curve analysis: Az: 0.650; sensitivity: 0.50; specificity: 0.80. The comparison between the results of FP-CIT and clinical manifestations showed: 4 patients with parkinsonism (PK) and pathological study; 4 without PK and normal study; 1 with PK and normal study and 1 without PK and pathological study.
Conclusions: FP-CIT study does not exclude completely the existence of an MSA-C. From a functional point of view, there does not always seem to be a consistency between the state of the nigro-striatal pathway and the existence of parkinsonism.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.medcli.2010.11.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Small Molecules, α-Synuclein Pathology, and the Search for Effective Treatments in Parkinson's Disease.
Int J Mol Sci
October 2024
Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
Parkinson's disease (PD) is a progressive age-related neurodegenerative disorder affecting millions of people worldwide. Essentially, it is characterised by selective degeneration of dopamine neurons of the nigro-striatal pathway and intraneuronal aggregation of misfolded α-synuclein with formation of Lewy bodies and Lewy neurites. Moreover, specific small molecules of intermediary metabolism may have a definite pathophysiological role in PD.
View Article and Find Full Text PDFCase Report: A Case of a Patient with Smith-Magenis Syndrome and Early-Onset Parkinson's Disease.
Int J Mol Sci
August 2024
Sagol Department of Neurobiology, University of Haifa, Haifa 3103301, Israel.
Article Synopsis
- - Smith-Magenis Syndrome (SMS) is a rare genetic disorder linked to intellectual disability, behavioral issues, and sleep problems, caused by a deletion in the chromosome band 17p11.2 affecting the RAI1 gene.
- - RAI1 plays a role in neurodevelopment and may be connected to Parkinson's disease (PD), which is characterized by motor symptoms like tremors and bradykinesia.
- - A case study of a patient with both SMS and early-onset PD raises questions about the relationship between RAI1 gene variations and PD, highlighting the need for more research and attention from caregivers regarding potential PD symptoms in SMS patients.
Behavioral effects of 6-hydroxydopamine-induced damage to nigro-striatal pathway and Locus coeruleus as a rodent model of Parkinson's disease.
Behav Brain Res
March 2024
Department of Physiological Sciences, Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP 01221-020, Brazil. Electronic address:
Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the Substantia nigra pars compacta (SNpc), which leads to motor and non-motor symptoms (NMS). NMS can appear many years before the classical motor symptoms and are associated with the neurodegeneration of several nuclei; in this work, we highlight the neurodegeneration of Locus coeruleus (LC) in PD. The aim was to investigate the effects of depleting SNpc and LC catecholaminergic neurons on behavioral and neurobiological endpoints.
View Article and Find Full Text PDFChanges in tissue protein -glycosylation and associated molecular signature occur in the human Parkinsonian brain in a region-specific manner.
PNAS Nexus
January 2024
CÚRAM, SFI Research Centre for Medical Devices, University of Galway, H91 TK33, Galway, Ireland.
Parkinson's disease (PD) associated state of neuroinflammation due to the aggregation of aberrant proteins is widely reported. One type of post-translational modification involved in protein stability is glycosylation. Here, we aimed to characterize the human Parkinsonian nigro-striatal -glycome, and related transcriptome/proteome, and its correlation with endoplasmic reticulum (ER) stress and unfolded protein response (UPR), providing a comprehensive characterization of the PD molecular signature.
View Article and Find Full Text PDFUnravelling the Parkinson's puzzle, from medications and surgery to stem cells and genes: a comprehensive review of current and future management strategies.
Exp Brain Res
January 2024
Centre for Neuroscience, Department of Biotechnology, Cochin University for Science and Technology, Kochi, Kerala, 682 022, India.
Parkinson's disease (PD) is a neurodegenerative disorder, prevalent in the elderly population. Neuropathological hallmarks of PD include loss of dopaminergic cells in the nigro-striatal pathway and deposition of alpha-synuclein protein in the neurons and synaptic terminals, which lead to a complex presentation of motor and non-motor symptoms. This review focuses on various aspects of PD, from clinical diagnosis to currently accepted treatment options, such as pharmacological management through dopamine replacement and surgical techniques such as deep brain stimulation (DBS).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!